# An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis

> **NCT01769339** · PHASE4 · COMPLETED · sponsor: **Janssen Pharmaceutica** · enrollment: 115 (actual)

## Conditions studied

- Vulva; Candidiasis

## Interventions

- **DRUG:** Miconazole plus Hydrocortisone

## Key facts

- **NCT ID:** NCT01769339
- **Lead sponsor:** Janssen Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2013-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01769339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01769339, "An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01769339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*